We’re proud to be partnering with the People First Community Lottery (formerly People’s Choice Community Lottery) in 2026. Every ticket you purchase helps fund vital melanoma research focused on better treatments, earlier detection and prevention.
Since its inception in 1984, the People First Community Lottery has raised more than $22 million for community organisations, helping charities like the Australian Melanoma Research Foundation create lasting impact.
For more than 20 years, AMRF has been investing in Australia’s brightest melanoma researchers, supporting the next generation of scientific leaders as they work towards the next breakthrough in melanoma research.
Every $2 ticket sold directly supports this important work, helping fund innovative research that has the potential to improve survival rates, detect melanoma earlier and ultimately prevent the disease.
Together, we can work towards a future where fewer Australians are diagnosed with advanced melanoma and more lives are saved.
Thank you for your support, and good luck



